GSTP2: A Potential Drug Target for Xenobiotics and Inflammation

Target Name: GSTTP2

NCBI ID: G653399

GSTTP2

Other Name(s): Glutathione S-transferase theta pseudogene 2 | glutathione S-transferase theta pseudogene 2

GSTP2: A Potential Drug Target for Xenobiotics and Inflammation

Glutathione S-transferase theta pseudogene 2 (GSTTP2) is a gene that has been identified as a potential drug target or biomarker in several studies. GSTP2 is a member of the GSTP2 family, which is involved in the detoxification of xenobiotics, such as drugs and environmental toxins, and is a key enzyme in the antioxidant system.

The GSTP2 gene has been shown to be expressed in various tissues and cells, including the liver, muscle, and brain, and has been implicated in the detoxification of a wide variety of xenobiotics, including drugs such as chemotherapy drugs, benzodiazepines, and arsenic.

One of the key functions of GSTP2 is its role in the detoxification of arsenic, which is a highly toxic and toxic compound that can cause a wide range of health problems, including skin damage, hearing loss, and damage to the cardiovascular system. Arsenic is often used in wood preservatives, and its use can lead to arsenic toxicity.

In addition to its role in arsenic detoxification, GSTP2 has also been shown to be involved in the detoxification of other xenobiotics, including chemotherapy drugs and environmental toxins such as polychlorinated biphenyls (PCBs). These xenobiotics can cause a wide range of health problems, including cancer, reproductive problems, and developmental delays.

GSTP2 has also been shown to be involved in the regulation of cellular processes, including cell signaling, DNA replication, and apoptosis. It has been shown to play a role in the development and progression of certain diseases, including cancer.

In addition to its role in the detoxification of xenobiotics and its involvement in cellular processes, GSTP2 has also been shown to be a potential drug target. Several studies have shown that GSTP2 can be modulated with small molecules, including inhibitors of GSTP2 have been shown to have a variety of therapeutic effects, including the inhibition of cancer cell growth and the inhibition of neurotoxicity.

GSTP2 has also been shown to be involved in the regulation of inflammation, which is a key factor in the development of many diseases, including cancer. It has been shown to play a role in the production of pro-inflammatory cytokines, which can contribute to the development of inflammation and the progression of diseases.

In conclusion, GSTP2 is a gene that has been shown to be involved in a wide range of cellular and physiological processes, including the detoxification of xenobiotics, cell signaling, DNA replication, and apoptosis, as well as the regulation of inflammation. Its potential as a drug target or biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of GSTP2 in the development and progression of diseases.

Protein Name: Glutathione S-transferase Theta Pseudogene 2

The "GSTTP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GSTTP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets